Skila Launches iAccess, a Global Market Access Management Solution
Morris Plains, NJ, April 20, 2009 – Skila, A Sela2 Company, announces the addition of iAccess to its suite of solutions, the first industry solution to provide a holistic view of key accounts for life science organizations looking to optimize their market access endeavors. iAccess enables knowledge agility and maximizes global market access efforts by allowing each country to quickly understand, plan for, and manage their key accounts, decision makers, stakeholders and influencer communities.
“We are very excited about iAccess™ and its unique ability to improve the way pharmaceutical market access teams work,” commented Susan Dorfman, VP Global Marketing, Skila. “iAccess is truly the first industry solution to allow Market Access teams to gain instant access to a 360-degree company view of their key accounts and customers combined with internal and external intelligence,” continues Ms. Dorfman. “More importantly, iAccess™ improves access, pull-through and relationship building with key stakeholders, enabling life science organizations not only to know and manage their key accounts and stakeholders but their spheres of influence as well.”
The iAccess solution modules include:
Market Access Planning Module for key account planning and objective alignment
Market Access Relationship Management Modules for account, stakeholder and program management
Performance Management Module for quick access to and real-time management of account and stakeholder performance
Best Practices Module for sharing learnings and best practices across the organization
Like all of Skila’s solutions, iAccess incorporates technology, methodology and services in order to maximize market access initiatives and enable life science organizations to improve access to key stakeholders by truly knowing their key accounts and the market.
About Skila
Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.
BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.